Pharmaceuticals
After China and Iraq, GSK now faces bribery probe in Poland
14 Apr 2014
British drug giant GlaxoSmithKline (GSK), is under a criminal probe for allegedly bribing doctors in Poland for prescribing its asthma drug Seretide
Natco Pharma opposes Indian patent for Gilead’s hepatitis drug
11 Apr 2014
Gilead, whose medicine has been hailed by doctors as a breakthrough in treating hepatitis, has come under fire over its product's $1,000 per pill price tag in the US
Ranbaxy drug flows to Europe, US to dry up
09 Apr 2014
Sun Pharmaceutical Industries plans to phase out sales of Ranbaxy’s branded generic drugs in the US while continuing sales in other markets
Takeda fined record $6 bn over diabetes drug Actos; Eli Lilly $3 bn
08 Apr 2014
Takeda Pharmaceutical Co Ltd, Japan's largest drug firm, has been fined a record $6 billion in punitive damages by a US court over claims that it concealed cancer risks associated with its best-selling diabetes drug Actos
Irish drugmaker Mallinckrodt to buy Questcor Pharmaceuticals for $5.6 bn
08 Apr 2014
Questcor's main product, the injectable drug Acthar Gel, which it acquired in 2001 from Aventis, is used in the treatment of 19 conditions, including multiple sclerosis and infantile spasms
Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal
07 Apr 2014
The merger will create India's largest pharmaceutical company and the world's fifth largest speciality generics company with annual emerging market sales nearing Rs6,000 crore
.webp)
.webp)
